End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.74 SEK | +2.74% | -10.13% | -11.32% |
May. 28 | Redsense Medical CEO to Step Down; CFO Named as Acting CEO | MT |
May. 27 | Redsense Medical’s CEO Steps Down | MT |
Sales 2022 | 16.75M 1.59M | Sales 2023 | 25.52M 2.42M | Capitalization | 107M 10.14M |
---|---|---|---|---|---|
Net income 2022 | -8M -760K | Net income 2023 | -4M -380K | EV / Sales 2022 | 7.31 x |
Net cash position 2022 | 10.58M 1.01M | Net cash position 2023 | 6.97M 662K | EV / Sales 2023 | 3.91 x |
P/E ratio 2022 |
-15.2
x | P/E ratio 2023 |
-23.8
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +2.74% | ||
1 week | -10.13% | ||
1 month | -14.90% | ||
3 months | +16.61% | ||
6 months | -18.20% | ||
Current year | -11.32% |
Managers | Title | Age | Since |
---|---|---|---|
Pontus Nobreus
CEO | Chief Executive Officer | 60 | 22-04-30 |
Jennie Kardell
DFI | Director of Finance/CFO | - | 22-12-31 |
Sebastien Bollue
COO | Chief Operating Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susanne Olausson
BRD | Director/Board Member | 53 | 12-12-31 |
Eva Walde
CHM | Chairman | 61 | 22-12-31 |
Malin Almgren
BRD | Director/Board Member | - | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6.74 | +2.74% | 2,311 |
24-05-29 | 6.56 | -2.09% | 6,954 |
24-05-28 | 6.7 | -2.90% | 15,666 |
24-05-27 | 6.9 | -8.00% | 9,467 |
End-of-day quote NORDIC GROWTH MARKET, May 30, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.32% | 8.98M | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- REDS Stock